Ministerio de Industria, Turismo y Comercio LogoMinisterior
 

Alerta

Resultados 265 resultados
LastUpdate Última actualización 27/04/2026 [08:33:00]
pdfxls
Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days
previousPage Resultados 150 a 175 de 265 nextPage  

Composition for predicting permeability of Blood-Brain Barrier

NºPublicación:  KR20260037573A 17/03/2026
Solicitante: 
연세대학교산학협력단
KR_20260037573_PA

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

一种基于单分子免疫法检测APOE3和/或APOE4的试剂组合及其应用

NºPublicación:  CN121679041A 17/03/2026
Solicitante: 
合肥国研汉因检测科技有限公司
CN_121679041_PA

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

补体相关性疾病靶向防治全自动分析仪检测补体的试剂盒及方法

NºPublicación:  CN121679030A 17/03/2026
Solicitante: 
杭州康知生物科技有限公司
CN_121679030_PA

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

一种免标记FRET增强型荧光组胺RNA生物传感器

NºPublicación:  CN121674405A 17/03/2026
Solicitante: 
中国农业大学
CN_121674405_PA

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

ONOO- Multifunctional fluorescent probes for successively detection of endogenous ONOO- and mitochondrial viscosity

NºPublicación:  KR20260036808A 17/03/2026
Solicitante: 
국립강릉원주대학교산학협력단
KR_20260036808_PA

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

Fluorescent Probes for Fluoride Ion Detection

NºPublicación:  KR20260036809A 17/03/2026
Solicitante: 
국립강릉원주대학교산학협력단
KR_20260036809_PA

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

慢性的ストレス状態を評価するためのバイオマーカーパネル

NºPublicación:  JP2026048281A 17/03/2026
Solicitante: 
国立研究開発法人産業技術総合研究所
JP_2026048281_A

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

核桃肽在制备认知功能改善剂中的应用

NºPublicación:  CN121648252A 13/03/2026
Solicitante: 
南昌大学
CN_121648252_PA

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

神经系统疾病特别是运动神经元疾病的肽生物标志物

NºPublicación:  CN121666456A 13/03/2026
Solicitante: 
豪夫迈·罗氏有限公司
CN_121666456_A

Resumen de: US2018099049A1

Stable lyophilized therapeutic protein compositions and their methods of manufacture are provided. Specifically, the use of water as a solid cake plasticizer and protein stabilizer is described. Also, the inclusion of a multicomponent stabilizer comprising a larger molecular entity and a smaller molecular entity is described. Also, the inclusion of post-drying annealing under certain conditions improves protein stability. Proteins are predicted to remain stable over 24 months at 25° C.

响应面法优化萌芽核桃种子蛋白最佳缓冲液萃取试验方法

NºPublicación:  CN121655982A 13/03/2026
Solicitante: 
四川农业大学
CN_121655982_PA

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

TRPM7激活剂在制备阿尔茨海默病治疗产品中的应用

NºPublicación:  CN121648293A 13/03/2026
Solicitante: 
复旦大学
CN_121648293_A

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

PROTEIN MARKERS FOR NEURODEGENERATIVE DISEASES

NºPublicación:  WO2026051874A1 12/03/2026
Solicitante: 
THE HONG KONG UNIV OF SCIENCE AND TECHNOLOGY [CN]
HONG KONG CENTER FOR NEURODEGENERATIVE DISEASES LTD [CN]
THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY,
HONG KONG CENTER FOR NEURODEGENERATIVE DISEASES LIMITED
WO_2026051874_PA

Resumen de: WO2026051874A1

Provided are diagnostic and treatment methods,based on plasma protein markers for neurodegenerative diseases such as mild cognitive impairment (MCI) and Alzheimer's Disease (AD),as well as kits for diagnosing and/or treating these condition.Machine learning systems and methods for assessing the risk for a subject having a neurodegenerative disease based on measured protein marker levels are also provided.

STABILIZED CIRCULATING PEPTIDES AND USES THEREOF

NºPublicación:  WO2026055173A1 12/03/2026
Solicitante: 
HALCYON THERAPEUTICS INC [US]
HALCYON THERAPEUTICS, INC
WO_2026055173_PA

Resumen de: WO2026055173A1

The present invention provides a method for identifying a subject having a stabilized circulating peptide. The method comprises detecting the stabilized circulating peptide in a body fluid sample, for example, a serum or plasma sample, from the subject. The method may further comprise treating a neurodegenerative disease, or monitoring or adjusting a treatment of a neurodegenerative disease. Also provided is a kit. The kit comprises a binding protein that specifically binds a stabilized circulating peptide in a body fluid sample, for example, a serum or plasma sample, from a subject. The kit may further comprise an agent for detecting, treating or monitoring a neurodegenerative disease in the subject. The neurodegenerative disease may be Alzheimer disease.

METHODS FOR AIDING IN DIAGNOSING AND EVALUATING A TRAUMATIC BRAIN INJURY IN A HUMAN SUBJECT USING A COMBINATION OF GFAP AND UCH-L1

NºPublicación:  US20260072042A1 12/03/2026
Solicitante: 
ABBOTT LAB [US]
US_20260072042_PA

Resumen de: US20260072042A1

0000 Disclosed herein are methods of aiding in the diagnosis and evaluation of a subject that has sustained or may have sustained an injury to the head. For example, the present disclosure provides methods for aiding in the diagnosis and evaluation of a subject to determine whether the subject has sustained a traumatic brain injury (TBI) by detecting or measuring a combination of the levels of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) in samples taken at various time points within 48 hours after the subject has sustained or may have sustained an injury to the head.

DEVICE FOR PERSONAL PREDICTIVE ENRICHMENT OF A BIOMARKER AND METHODS OF USE THEREOF

NºPublicación:  US20260072023A1 12/03/2026
Solicitante: 
KELLY SEAN M [US]
US_20260072023_PA

Resumen de: US20260072023A1

Methods and devices for enriching a target biomarker from a bodily fluid of a subject are provided. A risk profile for the subject is used to predict that a target biomarker is present in the bodily fluid. The bodily fluid is contacted with a set of immuno-affinity inserts coated with affinity molecules specific for the target biomarker under conditions for the affinity molecules to bind the target biomarker. The affinity molecules bound to the target biomarker are separated from the bodily fluid.

Universal Efficient Dextran Microparticles Production with Microfluidic Technology

NºPublicación:  US20260071176A1 12/03/2026
Solicitante: 
SANOFI SA [FR]
PASTEUR INSTITUT [FR]
COMMISSARIAT ENERGIE ATOMIQUE [FR]
US_20260071176_PA

Resumen de: US20260071176A1

0000 The present invention relates to the use of modified dextran hydrogel microparticles comprising (i) at least one vinyl sulfone functionalized dextran, and (ii) at least one crosslinkable polymer having at least two thiol functions, wherein the dextran has a molecular weight comprised between 5 and 500 kDa, and the substitution degree of the dextran by the vinyl sulfone is comprised between 5 and 60%, for encapsulating at least one synthetic or natural cell. The present invention also relates to modified dextran hydrogel microparticles, a process for preparing them, an in vitro method for cultivating at least one cell comprised in said microparticles, in vitro methods for screening, for producing or for testing compounds, a kit, a microfluidic or millifluidic channel, a process for encapsulating said microparticles, and a method for the quality control of a batch. Said microparticles are useful in the field of biological and medical applications.

SOLID-PHASE CARRIER FOR DETECTING OR SEPARATING/PURIFYING CELLS AND/OR EXTRACELLULAR VESICLES

NºPublicación:  US20260072026A1 12/03/2026
Solicitante: 
RNAI INC [JP]
US_20260072026_A1

Resumen de: US20260072026A1

The purpose of the present invention is to provide a new technique for trapping cells and/or extracellular vesicles (EVs) without using antibodies. The present invention is a solid-phase carrier having an ability to adsorb cells and/or extracellular vesicles, and comprising a substrate and an ion exchanger.

METHODS OF USING NEUROFILAMENT LIGHT CHAIN IMMUNOASSAYS

NºPublicación:  AU2024366503A1 12/03/2026
Solicitante: 
SIEMENS HEALTHCARE DIAGNOSTICS INC
SIEMENS HEALTHCARE DIAGNOSTICS INC
AU_2024366503_PA

Resumen de: AU2024366503A1

Methods, kits and compositions of detecting analytes, typically analytes relevant to neurodegenerative diseases such as neurofilament light chain, in a sample are described herein using chemiluminescent labels. Solid supports, reagents, and compounds for use in these methods are also described. Typically, the methods involve specific assay formats which provide the requisite high resolution for detecting low concentrations of analytes in samples and may be used in positions of the healthcare ecosystem close to the patient. These methods, systems, and apparatuses may afford early detection and prognosis of a wide variety of neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis.

METHODS AND COMPOSITIONS FOR T CELL THERAPY

NºPublicación:  US20260072034A1 12/03/2026
Solicitante: 
KITE PHARMA INC [US]
US_20260072034_PA

Resumen de: US20260072034A1

0000 The disclosure relates to methods of diagnosis and prognosis, compositions for immunotherapies, methods of improving said compositions, and immunotherapies using the same

METHOD FOR DETECTING LYSOSOMAL STORAGE DISEASE BIOMARKERS AND KITS FOR PERFORMING THE METHOD

NºPublicación:  US20260072045A1 12/03/2026
Solicitante: 
UNIV ANTWERPEN [BE]
UNIV ZIEKENHUIS ANTWERPEN [BE]
US_20260072045_PA

Resumen de: US20260072045A1

The present invention provides methods for detecting multiple biomarkers indicative for lysosomal storage diseases from a dried blood spot. In particular, the present invention provides a method that is suited for detecting multiple biomarkers, each indicative for the presence of a distinct lysosomal storage disease in a subject, based on a single sample preparation procedure. In particular, the method allows simultaneous extraction of different biomarkers such as Lyso-Gb1 (GlcSph). Lyso-Gb3, and others from a dried blood spot sample. The invention further provides a kit of parts comprising means for conducting the methods subject of the invention. Finally, the invention provides a set of reference ranges for Lyso-Gb1 (GlcSph) and Lyso-Gb3 in healthy subjects starting from dried blot spot samples.

METHOD FOR MEASURING CELL FREE CHROMATIN

NºPublicación:  US20260072040A1 12/03/2026
Solicitante: 
BELGIAN VOLITION SRL [BE]
Belgian Volition SRL
US_20260072040_A1

Resumen de: US20260072040A1

The invention relates to methods and uses of cell free histone H3 isoforms H3.1, H13.2, H3t and/or H3.3 (or cell free nucleosomes containing said isoforms) of determining the origin of a cell free histone or cell free nucleosome in a body fluid sample as originating from a dividing or non-dividing cell.

METHOD OF DETERMINING THE PRESENCE OR ABSENCE OF A TARGET ANALYTE COMPRISING USING A REPORTER POLYNUCLEOTIDE AND A TRANSMEMBRANE PORE

NºPublicación:  US20260072019A1 12/03/2026
Solicitante: 
OXFORD NANOPORE TECH PLC [GB]
US_20260072019_PA

Resumen de: US20260072019A1

The invention relates to a method of determining the presence or absence of a target analyte in a sample. The method comprises immobilising any target analyte present in the sample on a surface; contacting the surface with: (i) a first detection agent that binds specifically to the target analyte; and (ii) a reporter polynucleotide, wherein the reporter polynucleotide is bound to, or binds to, the first detection agent; and contacting a transmembrane pore with any reporter polynucleotide that has been immobilised on the surface, wherein the reporter polynucleotide is immobilised on the surface by binding of the first agent to the target analyte, and using the transmembrane pore to detect the reporter polynucleotide, thereby determining the presence or absence of the target analyte in the sample.

COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES WITH ANTI-CLL-1 DIRECTED THERAPY

NºPublicación:  WO2026055708A1 12/03/2026
Solicitante: 
SOVEREIGN MIDDLEMAN AND RILEY LLC [US]
WO_2026055708_PA

Resumen de: WO2026055708A1

Disclosed are methods of treating autoimmune diseases by administering engineered T cells expressing a chimeric antigen receptor (CAR) that specifically binds C-type lectin-like molecule-1 (CLL-1). The CAR-T cells deplete CLL-1–expressing monocyte-derived macrophages that replace yolk sac–derived or other embryonically derived tissue-resident macrophages, thereby reducing inflammation and disease progression. The methods are applicable to multiple sclerosis and other autoimmune disorders.

SINGLE-STRANDED DNA MOLECULAR RECOGNITION ELEMENTS AGAINST CYANOTOXIN L-BMAA

NºPublicación:  US20260071989A1 12/03/2026
Solicitante: 
UNIV PUERTO RICO [US]
US_20260071989_PA

Resumen de: US20260071989A1

0000 The present disclosure provides aptamers comprising a nucleotide sequence for binding β-N-methylamino-L-alanine (L-BMAA) or an isomer thereof as well as electrochemical aptamer-based sensor (EAB) compositions that include the aptamers. Further, methods of detecting β-N-methylamino-L-alanine (L-BMAA) or an isomer in a sample are also provided in order to identify presence of L-BMAA in the sample.

ANTIBODY-PEPTIDE FUSION PROTEINS FOR TREATING AMYLOID DISORDERS

Nº publicación: WO2026055521A1 12/03/2026

Solicitante:

UNIV TENNESSEE RES FOUND [US]

WO_2026055521_PA

Resumen de: WO2026055521A1

Provided herein are amyloid-reactive peptides and antibody-peptide fusion proteins. Also provided herein are methods of treating amyloid-based diseases by administering an antibody-peptide fusion protein.

traducir